Integral Health Asset Management, LLC Ventyx Biosciences, Inc. Transaction History

Integral Health Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$2.08 - $31.18 $145,600 - $2.18 Million	70,000 Added 16.28%	500,000 $1.24 Million
Q3 2023 Nov 14, 2023	BUY	$29.8 - $40.3 $2.38 Million - $3.22 Million	80,000 Added 22.86%	430,000 $14.9 Million
Q2 2023 Aug 11, 2023	BUY	$28.53 - $39.55 $1.71 Million - $2.37 Million	60,000 Added 20.69%	350,000 $11.5 Million
Q1 2023 May 09, 2023	BUY	$29.51 - $46.65 $2.36 Million - $3.73 Million	80,000 Added 38.1%	290,000 $9.72 Million
Q4 2022 Feb 13, 2023	BUY	$24.16 - $36.38 $2.66 Million - $4 Million	110,000 Added 110.0%	210,000 $6.89 Million
Q3 2022 Nov 14, 2022	BUY	$12.64 - $38.7 $1.26 Million - $3.87 Million	100,000 New	100,000 $3.49 Million

125

52.9M

35.3K

83K

Ticker VTYX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,527,200
Market Cap $128M
Description
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.